61 related articles for article (PubMed ID: 33992929)
1. Design, synthesis and biological evaluation of 3, 4-disubstituted-imidazolidine-2, 5-dione derivatives as HDAC6 selective inhibitors.
Liang T; Xue J; Yao Z; Ye Y; Yang X; Hou X; Fang H
Eur J Med Chem; 2021 Oct; 221():113526. PubMed ID: 33992929
[TBL] [Abstract][Full Text] [Related]
2. Design and Synthesis of Dihydroxamic Acids as HDAC6/8/10 Inhibitors.
Morgen M; Steimbach RR; Géraldy M; Hellweg L; Sehr P; Ridinger J; Witt O; Oehme I; Herbst-Gervasoni CJ; Osko JD; Porter NJ; Christianson DW; Gunkel N; Miller AK
ChemMedChem; 2020 Jul; 15(13):1163-1174. PubMed ID: 32348628
[TBL] [Abstract][Full Text] [Related]
3. Groebke Blackburn Bienaymé-mediated multi-component synthesis of selective HDAC6 inhibitors with anti-inflammatory properties.
Kraft FB; Enns J; Honin I; Engelhardt J; Schöler A; Smith ST; Meiler J; Schäker-Hübner L; Weindl G; Hansen FK
Bioorg Chem; 2024 Feb; 143():107072. PubMed ID: 38185013
[TBL] [Abstract][Full Text] [Related]
4. Design, synthesis, and biological evaluation of HDAC6 inhibitors targeting L1 loop and serine 531 residue.
Jha S; Kim JH; Kim M; Nguyen AH; Ali KH; Gupta SK; Park SY; Ha E; Seo YH
Eur J Med Chem; 2024 Feb; 265():116057. PubMed ID: 38142511
[TBL] [Abstract][Full Text] [Related]
5. Structural determinants of affinity and selectivity in the binding of inhibitors to histone deacetylase 6.
Osko JD; Christianson DW
Bioorg Med Chem Lett; 2020 Apr; 30(8):127023. PubMed ID: 32067866
[TBL] [Abstract][Full Text] [Related]
6. A novel HDAC6 inhibitor interferes microtubule dynamics and spindle assembly checkpoint and sensitizes cisplatin-induced apoptosis in castration-resistant prostate cancer.
Ye PC; Leu WJ; Yeh TY; Hsu YT; Lin YC; Wei ZY; Chen YC; Chiang YC; Hsu JL; Chan SH; Hsu LC; Chern JW; Yu CW; Guh JH
Prostate; 2024 May; 84(6):605-619. PubMed ID: 38375594
[TBL] [Abstract][Full Text] [Related]
7. Recent development of selective inhibitors targeting the HDAC6 as anti-cancer drugs: Structure, function and design.
Peng J; Xie F; Qin P; Liu Y; Niu H; Sun J; Xue H; Zhao Q; Liu J; Wu J
Bioorg Chem; 2023 Sep; 138():106622. PubMed ID: 37244230
[TBL] [Abstract][Full Text] [Related]
8. HDAC6 detector: online application for evaluating compounds as potential histone deacetylase 6 inhibitors.
Tinkov OV; Grigorev VY; Grigoreva LD; Osipov VN; Kolotaev AV; Khachatryan DS
SAR QSAR Environ Res; 2023; 34(8):619-637. PubMed ID: 37565331
[TBL] [Abstract][Full Text] [Related]
9. Design, Synthesis, and Antiproliferative Activity of Selective Histone Deacetylases 6 Inhibitors Containing a Tetrahydropyridopyrimidine Scaffold.
Wang B; Liu Y; Zhang L; Wang Y; Li Z; Chen X
Molecules; 2023 Oct; 28(21):. PubMed ID: 37959743
[TBL] [Abstract][Full Text] [Related]
10. Benzothiazole derivatives as histone deacetylase inhibitors for the treatment of autosomal dominant polycystic kidney disease.
Cao X; Fan Z; Xu L; Zhao W; Zhang H; Yang Y; Ren Y; Xiao Y; Zhou N; Yin L; Zhou X; Zhu X; Guo D
Eur J Med Chem; 2024 May; 271():116428. PubMed ID: 38653068
[TBL] [Abstract][Full Text] [Related]
11. Exploring Structural Determinants of Inhibitor Affinity and Selectivity in Complexes with Histone Deacetylase 6.
Osko JD; Porter NJ; Narayana Reddy PA; Xiao YC; Rokka J; Jung M; Hooker JM; Salvino JM; Christianson DW
J Med Chem; 2020 Jan; 63(1):295-308. PubMed ID: 31793776
[TBL] [Abstract][Full Text] [Related]
12. A patent review of histone deacetylase 6 inhibitors in neurodegenerative diseases (2014-2019).
Shen S; Kozikowski AP
Expert Opin Ther Pat; 2020 Feb; 30(2):121-136. PubMed ID: 31865813
[No Abstract] [Full Text] [Related]
13. Development of a tetrahydroindazolone-based HDAC6 inhibitor with in-vivo anti-arthritic activity.
Yang HM; Lee C; Min J; Ha N; Bae D; Nam G; Park HJ
Bioorg Med Chem; 2024 Feb; 99():117587. PubMed ID: 38237257
[TBL] [Abstract][Full Text] [Related]
14. Re-exploration of tetrahydro-β-carboline scaffold: Discovery of selective histone deacetylase 6 inhibitors with neurite outgrowth-promoting and neuroprotective activities.
Wen W; Hu J; Wang C; Yang R; Zhang Y; Huang B; Qiao T; Wang J; Chen X
Bioorg Med Chem Lett; 2024 Apr; 102():129670. PubMed ID: 38387692
[TBL] [Abstract][Full Text] [Related]
15. Aplysinopsin analogs: Synthesis and anti-proliferative activity of substituted (Z)-5-(N-benzylindol-3-ylmethylene)imidazolidine-2,4-diones.
Thirupathi Reddy Y; Narsimha Reddy P; Koduru S; Damodaran C; Crooks PA
Bioorg Med Chem; 2010 May; 18(10):3570-4. PubMed ID: 20403701
[TBL] [Abstract][Full Text] [Related]
16. Selective and Bioavailable HDAC6 2-(Difluoromethyl)-1,3,4-oxadiazole Substrate Inhibitors and Modeling of Their Bioactivation Mechanism.
Ripa L; Sandmark J; Hughes G; Shamovsky I; Gunnarsson A; Johansson J; Llinas A; Collins M; Jung B; Novén A; Pemberton N; Mogemark M; Xiong Y; Li Q; Tångefjord S; Ek M; Åstrand A
J Med Chem; 2023 Oct; 66(20):14188-14207. PubMed ID: 37797307
[TBL] [Abstract][Full Text] [Related]
17. Design, synthesis, and anti-inflammatory activity characterization of novel brain-permeable HDAC6 inhibitors.
Liu G; Mondal P; Sang N; Li Z; Ding W; Yang L; Liu Y; Birar VC; Gomm A; Tanzi RE; Zhang C; Shen S; Wang C; Lu X; Bai P
Eur J Med Chem; 2023 Jun; 254():115327. PubMed ID: 37098307
[TBL] [Abstract][Full Text] [Related]
18. Structure-based prediction of HDAC6 substrates validated by enzymatic assay reveals determinants of promiscuity and detects new potential substrates.
Varga JK; Diffley K; Welker Leng KR; Fierke CA; Schueler-Furman O
Sci Rep; 2022 Feb; 12(1):1788. PubMed ID: 35110592
[TBL] [Abstract][Full Text] [Related]
19. Integrated molecular modeling and dynamics approaches revealed the mechanism of selective inhibition of HDAC6/8.
Li Y; Liu S; Xu X; Xu J; Yang L; Hu L
J Biomol Struct Dyn; 2023 Oct; ():1-14. PubMed ID: 37870047
[TBL] [Abstract][Full Text] [Related]
20. Corroborating evidence for aberrant expression of histone deacetylase 8 in endometriosis.
Zheng H; Liu X; Guo SW
Reprod Med Biol; 2023; 22(1):e12527. PubMed ID: 37476367
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
